Trial Profile
A Study to Evaluate Pharmacokinetics and Potential Drug Interactions of a Fixed-dose Combination Tablet, HL-040XC, in Healthy Male Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 13 Mar 2013
Price :
$35
*
At a glance
- Drugs Atorvastatin/losartan (Primary) ; Atorvastatin; Losartan
- Indications Hyperlipidaemia; Hypertension
- Focus Pharmacokinetics
- 13 Mar 2013 New source identified and integrated: ClinicalTrials.gov record.
- 13 Mar 2013 Status changed from recruiting to completed, as reported by ClinicalTrals.gov.
- 23 Aug 2012 New trial record